BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1680095)

  • 21. Use of cetirizine to investigate non-H1 effects of second-generation antihistamines.
    Townley RG; Okada C
    Ann Allergy; 1992 Feb; 68(2):190-6. PubMed ID: 1346737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of antihistamines beyond H1 antagonism in allergic inflammation.
    Massey WA; Lichtenstein LM
    J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 2):1019-24. PubMed ID: 1979797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma.
    Rédier H; Chanez P; De Vos C; Rifaï N; Clauzel AM; Michel FB; Godard P
    J Allergy Clin Immunol; 1992 Aug; 90(2):215-24. PubMed ID: 1354225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of antihistamines on the immediate allergic response: a comparative review.
    Naclerio RM
    Otolaryngol Head Neck Surg; 1993 Jun; 108(6):723-30. PubMed ID: 8100058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cetirizine: antiallergic therapy beyond traditional H1 antihistamines.
    Sheffer AL; Samuels LL
    J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 2):1040-6. PubMed ID: 1979800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine.
    De Vos C; Joseph M; Leprevost C; Vorng H; Tomassini M; Capron M; Capron A
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):212-5. PubMed ID: 2523357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of cetirizine in the treatment of seasonal allergic rhinoconjunctivitis.
    Panayotopoulos SM; Panayotopoulou ES
    Ann Allergy; 1990 Aug; 65(2):146-8. PubMed ID: 1974401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of cetirizine and of terfenadine in the treatment of perennial allergic rhinitis].
    Boniver R; Arendt C
    Acta Otorhinolaryngol Belg; 1989; 43(1):75-81. PubMed ID: 2572140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Oral second generation antihistamines in allergic rhinitis].
    Riechelmann H
    Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do nasal mast cells release histamine on stimulation with substance P in allergic rhinitis?
    Braunstein G; Buvry A; Lacronique J; Desjardins N; Frossard N
    Clin Exp Allergy; 1994 Oct; 24(10):922-9. PubMed ID: 7531109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism.
    Ciprandi G; Tosca MA; Milanese M; Schenone G; Ricca V
    Eur Ann Allergy Clin Immunol; 2004 Feb; 36(2):67-70, 72. PubMed ID: 15061398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin.
    Michel L; De Vos C; Rihoux JP; Burtin C; Benveniste J; Dubertret L
    J Allergy Clin Immunol; 1988 Jul; 82(1):101-9. PubMed ID: 2899102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge.
    Charlesworth EN; Massey WA; Kagey-Sobotka A; Norman PS; Lichtenstein LM
    J Pharmacol Exp Ther; 1992 Sep; 262(3):964-70. PubMed ID: 1382132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacological and clinical properties of cetirizine hydrochloride].
    Uchida M; Nakahara H
    Nihon Yakurigaku Zasshi; 2000 Apr; 115(4):229-35. PubMed ID: 10876807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and in vitro effects of antihistamines on mast cell mediator release: a potentially important property in the treatment of allergic disease.
    Togias AG; Proud D; Kagey-Sobotka A; Freidhoff L; Lichtenstein LM; Naclerio RM
    Ann Allergy; 1989 Nov; 63(5):465-9. PubMed ID: 2573301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of eosinophil chemotaxis by a new antiallergic compound (cetirizine).
    Leprevost C; Capron M; De Vos C; Tomassini M; Capron A
    Int Arch Allergy Appl Immunol; 1988; 87(1):9-13. PubMed ID: 2971624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Onset of action in the nasal antihistaminic effect of cetirizine and loratadine in patients with allergic rhinitis.
    Frossard N; Lacronique J; Melac M; Benabdesselam O; Braun JJ; Glasser N; Pauli G
    Allergy; 1997 Feb; 52(2):205-9. PubMed ID: 9105526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Participation of histamine H3 receptors in experimental allergic rhinitis of mice.
    Yokota E; Kuyama S; Sugimoto Y; Ogawa M; Kamei C
    J Pharmacol Sci; 2008 Oct; 108(2):206-11. PubMed ID: 18845911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation of cetirizine].
    Tarchalska-Kryńska B; Zawisza E
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):123-6. PubMed ID: 1977153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of loratadine and terfenadine on the induced nasal allergic reaction.
    Baroody FM; Lim MC; Proud D; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
    Arch Otolaryngol Head Neck Surg; 1996 Mar; 122(3):309-16. PubMed ID: 8607960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.